Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Oxyvision is an oral nutraceutical tablet developed by Eyekare Kilitch to support overall eye health and assist in the management of conditions like glaucoma. The formulation contains a combination of natural antioxidants and essential nutrients, including bilberry extract, pine bark extract, lutein, astaxanthin, zeaxanthin, and essential vitamins and minerals (such as vitamins A, C, and E, zinc, copper, and selenium). These ingredients work synergistically to reduce intraocular pressure, improve blood vessel lining, decrease capillary permeability, and protect ocular tissues from oxidative stress and inflammation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Oxyvision.